Yayın: Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: : A phase iv randomized study.
| dc.contributor.author | Atahan, L. | |
| dc.contributor.author | Yildiz, F. | |
| dc.contributor.author | Cengiz, M. | |
| dc.contributor.author | Kaplan, B. | |
| dc.contributor.author | Özkan, M. | |
| dc.contributor.author | Haydaroglu, A. | |
| dc.contributor.author | Sengoz, M. | |
| dc.contributor.author | Korcums, A. F. | |
| dc.contributor.author | Akmansu, M. | |
| dc.contributor.buuauthor | Engin, Kayıhan | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Onkoloji Ana Bilim Dalı | |
| dc.contributor.researcherid | CQB-5826-2022 | |
| dc.date.accessioned | 2024-11-28T06:17:14Z | |
| dc.date.available | 2024-11-28T06:17:14Z | |
| dc.date.issued | 2006-01-01 | |
| dc.description | Bu çalışma, 05-09 Kasım 2006 tarihleri arasında Philadelphia[ABD]’da düzenlenen 48. Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology’da bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | Amer Soc Therapeut Radiol & Oncol | |
| dc.identifier.endpage | S525 | |
| dc.identifier.issn | 0360-3016 | |
| dc.identifier.issue | 3, SupplementS | |
| dc.identifier.startpage | S524 | |
| dc.identifier.uri | https://hdl.handle.net/11452/48619 | |
| dc.identifier.volume | 66 | |
| dc.identifier.wos | 000241221602079 | |
| dc.indexed.wos | WOS.ISTP | |
| dc.indexed.wos | WOS.SCI | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Science Inc | |
| dc.relation.journal | International Journal Of Radiation Oncology Biology Physics | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Science & technology | |
| dc.subject | Life sciences & biomedicine | |
| dc.subject | Radiology, nuclear medicine & medical imaging | |
| dc.subject | Oncology | |
| dc.title | Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: : A phase iv randomized study. | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Onkoloji Ana Bilim Dalı | |
| local.indexed.at | WOS |
